Abstract
To determine the genetic risk factors for venous thromboembolism (VTE), this study examined 14 genetic variants from 10 hemostatic genes in 186 Taiwanese VTE patients and the same number of matched controls, which demonstrated FGA (encoding α fibrinogen) Thr312Ala polymorphism was the only variant significantly associated with VTE. Nine genetic polymorphisms on the fibrinogen cluster region of chromosome 4q28 were further studied, in which four FGA polymorphisms were found in strong linkage disequilibrium and were significantly associated with VTE by genotype and allele frequency analyses. Haplotype analysis showed significantly different FGA haplotype frequencies between VTE patients and controls with the haplotype F1, containing -1051G, -3A, 312Ala and TaqI duplication alleles, significantly associated with susceptibility to VTE (P=0.001). Haplotype-pair analysis results also indicated a strong association of the haplotype-pair F1F1 with VTE in various VTE patient subgroups. In vitro functional analysis indicated that FGA -1051G, -3A and TaqI duplication alleles enhanced significantly the transcription level of FGA; however, control subjects with FGA genotypes containing these alleles had no elevated plasma fibrinogen levels. In conclusion, our experimental data indicated that functional genetic variants in FGA are risk factors for VTE in Taiwanese populations. Determination of FGA genotypes will likely contribute to primary prevention of this condition.
Similar content being viewed by others
References
Alhenc-Gelas M, Nicaud V, Gandrille S, van Dreden P, Amiral J, Aubry ML, Fiessinger JN, Emmerich J, Aiach M (1999) The factor V gene A4070G mutation and the risk of venous thrombosis. Thromb Haemost 81:193–197
Arnaud E, Barbalat V, Nicaud V, Cambien F, Evans A, Morrison C, Arveiler D, Luc G, Ruidavets JB, Emmerich J, Fiessinger JN, Aiach M (2000) Polymorphisms in the 5′ regulatory region of the tissue factor gene and the risk of myocardial infarction and venous thromboembolism: the ECTIM and PATHROS studies. Arterioscler Thromb Vasc Biol 20:892–898
Arnaud E, Nicaud V, Poirier O, Rendu F, Alhenc-Gelas M, Fiessinger JN, Emmerich J, Aiach M (2000) Protective effect of a thrombin receptor (protease-activated receptor 1) gene polymorphism toward venous thromboembolism. Arterioscler Thromb Vasc Biol 20:585–592
Baumann RE, Henschen AH (1993) Human fibrinogen polymorphic site analysis by restriction endonuclease digestion and allele-specific polymerase chain reaction amplification: identification of polymorphisms at positions Aα312 and Bβ448. Blood 82:2117–2124
Biguzzi E, Merati G, Liaw PC, Bucciarelli P, Oganesyan N, Qu D, Gu JM, Fetiveau R, Esmon CT, Mannucci PM, Faioni EM (2001) A 23bp insertion in the endothelial protein C receptor (EPCR) gene impairs EPCR function. Thromb Haemost 86:939–941
Blake GJ, Schmitz C, Lindpaintner K, Ridker PM (2001) Mutation in the promoter region of the beta-fibrinogen gene and the risk of future myocardial infarction, stroke and venous thrombosis. Eur Heart J 22:2262–2266
Carter AM, Catto AJ, Kohler HP, Ariens RA, Stickland MH, Grant PJ (2000) α-fibrinogen Thr312Ala polymorphism and venous thromboembolism. Blood 96:1177–1179
Castoldi E, Simioni P, Kalafatis M, Lunghi B, Tormene D, Girelli D, Girolami A, Bernardi F (2000) Combinations of 4 mutations (FV R506Q, FV H1299R, FV Y1702C, PT 20210G/A) affecting the prothrombinase complex in a thrombophilic family. Blood 96:1443–1447
Chan WP, Lee CK, Kwong YL, Lam CK, Liang R (1998) A novel mutation of Arg306 of factor V in Hong Kong Chinese. Blood 91:1135–1139
Fallin D, Cohen A, Essioux L, Chumakov I, Blumenfeld M, Cohen D, Schork N (2001) Genetic analysis of case/control data using estimated haplotype frequencies: application to APOE locus variation and Alzheimer’s disease. Genome Res 11:143–151
Folkes DM, Mullis NT, Comeau CM (1994) Potential basis for regulation of the coordinately expressed fibrinogen genes: homology in the 5’ flanking regions. Proc Natl Acad Sci USA 81:2313
Friedlander Y, Kark JD, Sinnreich R, Basso F, Humphries SE (2003) Combined segregation and linkage analysis of fibrinogen variability in Israeli families: evidence for two quantitative-trait loci, one of which is linked to a functional variant (-58G>A) in the promoter of the α-fibrinogen gene. Ann Hum Genet 67:228–241
Hiyoshi M, Arnutti P, Prayoonwiwat W, Nathalang O, Suwanasophon C, Kokaseam R, Hashimoto S, Takubo T, Tagawa S, Fukui M, Tatsumi N (1998) A polymorphism nt 1628G→A (R485K) in Exon 10 of the coagulation factor V gene may be a risk factor for thrombosis in the indigenous Thai population. Thromb Haemost 81:705
Hsu LA, Ko YL, Wu S, Teng MS, Peng TY, Chen CF, Chen CF, Lee YS (2003) Association between a novel 11-base pair deletion mutation in the promoter region of the scavenger receptor class B type I gene and plasma HDL cholesterol levels in Taiwanese Chinese. Arterioscler Thromb Vasc Biol 23:1869–74
Hu CH, Harris JE, Davie EW, Chung DW (1995) Characterization of the 5’-flanking region of the gene for the chain of human fibrinogen. J Biol Chem 270:28342–28349
Kamphuisen PW, Eikenboom JC, Vos HL, Pablo R, Sturk A, Bertina RM, Rosendaal FR (1999) Increased levels of factor VIII and fibrinogen in patients with venous thrombosis are not caused by acute phase reactions. Thromb Haemost 81:680–683
Kangsadalampai BS, Board PG (1998) The Val134Leu polymorphism in the α subunit of coagulation Factor XIII contributes to the large normal range in activity and demonstrates that the activation peptide plays a role in catalytic activity. Blood 92:2766–2770
Kleesiek K, Schmidt M, Gotting C, Schwenz B, Lange S, Muller-Berghaus G, Brinkmann T, Prohaska W (1999) The 536C→T transition in the human tissue factor pathway inhibitor (TFPI) gene is statistically associated with a higher risk for venous thrombosis. Thromb Haemost 82:1–5
Koster T, Rosendaal FR, Reitsma PH, van der Velden PA, Briet E, Vandenbroucke JP (1994) Factor VII and fibrinogen levels as risk factors for venous thrombosis. A case-control study of plasma levels and DNA polymorphisms – The Leiden Thrombophilia Study (LETS). Thromb Haemost 71:723–726
Lane DA, Grant PJ (2000) Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease. Blood 95:1517–1532
Le Flem L, Picard V, Emmerich J, Gandrille S, Fiessinger JN, Aiach M, Alhenc-Gelas M (1999) Mutations in promoter region of thrombomodulin and venous thromboembolic disease. Arterioscler Thromb Vasc Biol 19: 1098–1104
Lee LH (2002) Clinical update on deep venous thrombosis in Singapore. Ann Acad Med Singapore 31:248–52
Lim BC, Ariens RA, Carter AM, Weisel JW, Grant PJ (2003) Genetic regulation of fibrin structure and function: complex gene-environment interactions may modulate vascular risk. Lancet 361:1424–1431
Liu Y, Saha N, Heng CK, Hong S, Low PS (2001) Fibrinogen genotypes (α and β) are associated with plasma fibrinogen levels in Chinese. J Med Genet 38:e31
Maszbak L, Adany R, Mikkola H (1996) Novel aspects of blood coagulation factor XIII, I: structure, distribution, and function. Crit Rev Clin Lab Sci 33:357–421
Menegatti M, Asselta R, Duga S, Malcovati M, Bucciarelli P, Mannucci PM, Tenchini ML (2001) Identification of four novel polymorphisms in the Aα and γ fibrinogen genes and analysis of association with plasma levels of the protein. Thromb Res 103:299–307
Ott J (1977) Counting methods (EM algorithm) in human pedigree analysis: linkage and segregation analysis. Ann Hum Genet 40:443–454
Poort SR, Rosendaal FR, Reitsma PH, Bertina RM (1996) A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 88:3698–3703
Rees DC, Cox M, Clegg JB (1995) World distribution of factor V Leiden. Lancet 346:1133–1134
Remijn JA, van Wijk R, de Groot PG, van Solinge WW (2001) Nature of the fibrinogen Aα gene TaqI polymorphism. Thromb Haemost 86:945–946
Renner W, Cichocki L, Forjanics A, Koppel H, Gasser R, Pilger E (2002) G-455A polymorphism of the fibrinogen beta gene and deep vein thrombosis. Eur J Clin Invest 32:755–758
Standeven KF, Grant PJ, Carter AM, Scheiner T, Weisel JW, Ariens RA (2003) Functional analysis of the fibrinogen A α Thr312Ala polymorphisms. Effects on fibrin structure and function. Circulation 107:2326–2330
Välsänen S, Rauramaa R, Penttilä I, Rankinen T, Gagnon J, Pérusse L, Chagnon M, Bouchard C (1997) Variation in plasma fibrinogen over one year: relationships with genetic polymorphisms and non-genetic factors. Thromb Haemost 77:884–889
van ‘t Hooft FM, von Bahr SJ, Silveira A, Iliadou A, Eriksson P, Hamsten A (1999) Two common functional polymorphisms in the promoter region of the β fibrinogen gene contribute to regulation of plasma fibrinogen concentration. Arterioscler Thromb Vasc Biol 19:3063–3070
Voorberg J, Roelse J, Koopman R, Buller H, Berends F, ten Cate JW, Mertens K, van Mourik JA (1994) Association of idiopathic venous thromboembolism with single point mutation at Arg506 of factor V. Lancet 343:1535–1536
Yu S, Sher B, Kudryk B, Redman CM (1984) Fibrinogen precursors: Order of assembly of fibrinogen chains. J Biol Chem 259:10574
Acknowledgement
The authors would like to thank Professor Daniele Fallin in the Bloomberg School of Public Health, John Hopkins University for her kind assistance in haplotype analysis. The authors would like to thank Chang-Gung Medical Research Program for financially supporting this research under Contract Nos. CMRP 754, 1115, G1014 and G32072.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Ko, YL., Hsu, LA., Hsu, TS. et al. Functional polymorphisms of FGA, encoding α fibrinogen, are associated with susceptibility to venous thromboembolism in a Taiwanese population. Hum Genet 119, 84–91 (2006). https://doi.org/10.1007/s00439-005-0102-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00439-005-0102-0